208292 Sigma-AldrichL-Type Calcium Channel Blocker
A cell-permeable sulfonamide compound that reversibly interacts with the benzothiazepine-binding site and acts as a cardiac tissue selective L-type voltage gated Ca2+-channel activity inhibitor.
More>> A cell-permeable sulfonamide compound that reversibly interacts with the benzothiazepine-binding site and acts as a cardiac tissue selective L-type voltage gated Ca2+-channel activity inhibitor. Less<<Synonymes: (N-Cyclopropyl-N-piperidin-4-yl)-4-chlorobenzenesulfonamide
Produits recommandés
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| CAS # | Empirical Formula |
|---|---|
| 387350-81-4 | C₁₄H₁₉ClN₂O₂S |
| References | |
|---|---|
| References | Carosati, E., et al. 2006. J. Med. Chem. 49, 5206. |
| Product Information | |
|---|---|
| CAS number | 387350-81-4 |
| ATP Competitive | N |
| Form | White solid |
| Hill Formula | C₁₄H₁₉ClN₂O₂S |
| Chemical formula | C₁₄H₁₉ClN₂O₂S |
| Reversible | Y |
| Structure formula Image | |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Cardiac tissue selective L-type voltage gated Ca2+-channel activity inhibitor |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN |
| 208292 | 0 |
Documentation
L-Type Calcium Channel Blocker Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| 208292 |
Références bibliographiques
| Aperçu de la référence bibliographique |
|---|
| Carosati, E., et al. 2006. J. Med. Chem. 49, 5206. |



